These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24670829)

  • 1. Paclitaxel-coated balloons for failing peripheral bypass grafts: the BYPACS study.
    Kitrou P; Parthipun A; Diamantopoulos A; Padayachee S; Karunanithy N; Ahmed I; Zayed H; Katsanos K
    J Cardiovasc Surg (Torino); 2014 Apr; 55(2):217-24. PubMed ID: 24670829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-coated versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis.
    Linni K; Ugurluoglu A; Aspalter M; Hitzl W; Hölzenbein T
    J Vasc Surg; 2016 Feb; 63(2):391-8. PubMed ID: 26492997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial.
    Katsanos K; Karnabatidis D; Kitrou P; Spiliopoulos S; Christeas N; Siablis D
    J Endovasc Ther; 2012 Apr; 19(2):263-72. PubMed ID: 22545894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous transluminal angioplasty with drug-eluting balloons for salvage of infrainguinal bypass grafts.
    San Norberto EM; Taylor JH; Carrera S; Vaquero C
    J Endovasc Ther; 2014 Feb; 21(1):12-21. PubMed ID: 24502479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial.
    Tepe G; Schnorr B; Albrecht T; Brechtel K; Claussen CD; Scheller B; Speck U; Zeller T
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):102-8. PubMed ID: 25616822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
    Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
    Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
    Trials; 2013 Mar; 14():87. PubMed ID: 23537403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access.
    Chen X; Liu Y; Wang J; Zhao J; Singh N; Zhang WW
    J Vasc Surg; 2020 Dec; 72(6):2186-2196.e3. PubMed ID: 32540324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting balloons and uncoated balloons perform equally to rescue infrainguinal autologous bypasses at risk.
    Jongsma H; Akkersdijk GP; de Smet AAEA; Vroegindeweij D; de Vries JPM; Fioole B
    J Vasc Surg; 2017 Aug; 66(2):454-460. PubMed ID: 28478021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon angioplasty for revision of failing lower extremity bypass grafts.
    Ali H; Elbadawy A; Saleh M; Hasaballah A
    J Vasc Surg; 2015 Jul; 62(1):93-100. PubMed ID: 25769387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitinol stents with polymer-free paclitaxel coating for stenosis of failing infrainguinal bypass grafts.
    Airoldi F; Baldino G; Mortola P; Losa S; Clerici G; Tavano D; Latib A; Gori A; Faglia E
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):441-5. PubMed ID: 24013532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality After Paclitaxel-Coated Device Use in Dialysis Access: A Systematic Review and Meta-Analysis.
    Dinh K; Limmer AM; Paravastu SCV; Thomas SD; Bennett MH; Holden A; Varcoe RL
    J Endovasc Ther; 2019 Oct; 26(5):600-612. PubMed ID: 31455140
    [No Abstract]   [Full Text] [Related]  

  • 16. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.
    Liistro F; Angioli P; Porto I; Ricci L; Ducci K; Grotti S; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2014 Feb; 21(1):1-8. PubMed ID: 24502477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Nerla R; Vadalà G; Castriota F; Grattoni C; Liso A; Russo P; Pantaleo P; Roscitano G; Cremonesi A
    JACC Cardiovasc Interv; 2017 Apr; 10(7):728-734. PubMed ID: 28385412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
    Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
    Katsanos K; Spiliopoulos S; Paraskevopoulos I; Diamantopoulos A; Karnabatidis D
    J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.